8th December 2005 - Board Minutes
Minutes of the Meeting of the Board of the Irish Blood Transfusion Service held on Thursday 8th December, 2005 at 1pm.in the Boardroom, National Blood Centre, Jamess Street, Dublin 8
Present: Ms. Maura McGrath (Chairperson)
Dr. Melanie Cotter
Ms. Jane OBrien
Mr. David Keenan
Mr. Sean Wyse
Mr. David Lowe
Dr. Mary Cahill
Dr. Mary Horgan
Mr. Tony McNamara
Mr. Mark Moran
Apologies: Dr. Liz Keane
Dr. Cees Van Der Poel
In Attendance: Mr. Andrew Kelly (CE)
Dr. William Murphy (NMD)
Mr. Michael Healy (SEO)
Minutes of Meeting10th November 2005
The minutes of the Board meeting held on Thursday, 10th November 2005, were adopted on the proposal of Mr M Moran, seconded by Dr M Cahill and signed by the Chairperson subject to agreed amendments.
2. Matters Arising
The EU Directive and Irish Regulations will be included in the January 2006 Board agenda when the National Quality Assurance Manager will be in attendance.
The CE briefed the Board on the issue of eProgesa implementation. The IBTS will continue its interaction in regard to eProgesa implementation with other sites. A number of possible courses of action were proposed. The CE will review the various options and will revert to the Board. The Chairperson suggested that it might be worthwhile inviting MAK representatives to meet the IBTS Board.
Deferred item from previous Board Meeting
- Minutes of MAC Meeting22nd September 2005
The Minutes were noted. Dr M Cahill briefed the Board on the proposed updated MAC Terms of Reference. The Board also discussed the possibility of changing the times of the MAC meeting in conjunction with the Board meeting. It was agreed that the Board would look again at holding meetings on Wednesday afternoons and the MAC could revert to meeting Wednesday mornings. The CE will revert to the Board on this matter.
The Board discussed the issue of clinical governance and the role the MAC might play in ensuring that best practice is carried out in the IBTS. It is proposed that a set of relevant Key Performance Indicators be developed, against which clinical governance in the IBTS could be assessed. It was agreed that the terms of reference of the MAC should be reviewed in light of the discussion on clinical governance. It was also agreed that the terms of reference should also refer to the requirement that recommendations need to be referred to the Executive to assess and quantify the non-medical impact on the organisation before presentation to Board for approval.
6. Minutes of MAC Meeting13th October 2005
The Minutes of the MAC Meeting 13/10/2005 were noted.
3. Allocation of Financial Resources
Mr D Lowe briefed the Board on the various options open to the Board in the allocation of the budgetary surplus.
4. Chief Executives Report
The CE report was noted.
Minutes of Finance Committee Meeting1/11/2005
The minutes were noted.
8. Correspondence
The correspondence from Dr C Molloy of the Blood Product Liaison Group Cork, requesting a meeting with the Chairperson in regard to the report of the Review Panel on Testing September 2002 was noted.
9. Future profile of the IBTS - discussion
The Chairperson informed the Board that she had met with Ms M ODonovan, Communications Manager, the CE and the external consultant to explore ways to improve the profile of the IBTS with a view to improving services and blood stock availability. A paper on the matter will come to Board in the near future.
10. Date and Venue of Next Meeting
The next meeting of the Board will take place in the NBC onWednesday January 11th 2006at 2pm.
The Chairperson thanked Mr Michael Healy, who is taking a career break, for his commitment and professionalism in dealing with the affairs of the Board.
Signed:&&&&&&&&&&.&&.. Date:&&&&&&&&
